Antenatal Steroids and Cardiometabolic Risk
Antenatal Steroids and Cardiometabolic Risk
批准号:
8381685
负责人:
JAMES C. ROSE
金额:
$47.8万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-20 至 2016-08-31
关键词:
14 year old19 year oldAdolescentAdrenal Cortex HormonesAlbuminsAngiotensin IIAngiotensinsAutonomic nervous systemBaroreflexBlood PressureCardiovascular systemCaringChronic DiseaseDataDietDiseaseEquilibriumEventExcretory functionExposure toFetusGestational AgeGlucose IntoleranceGoalsGrowthHealthHumanHypertensionIndividualInfantInstructionInsulin ResistanceInterventionKidneyLeptinLifeLong-Term EffectsMetabolicMetabolic DiseasesMonitorNatriuresisNeonatalNeonatal MortalityNephronsOGTTObesityOutcomePeptidyl-Dipeptidase APhysical activityPhysiologicalPopulationPregnancyPregnant WomenPremature BirthPrevention strategyPrincipal InvestigatorRenin-Angiotensin SystemRestRiskRisk FactorsRosaSheepSodiumSteroidsStressTestingUnited StatesVery Low Birth Weight Infantadipokinesadiponectinbody systemcohortdesigndisorder riskheart rate variabilityimprovedindexinginsightinsulin sensitivityneonatal morbiditypeerpostnatalprenatalprenatal exposurepressureprogramsresistinresponsetreatment strategyurinaryyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Antenatal corticosteroid (ANCS) treatment is recommended for all pregnant women expected to deliver
between 24 and 34 weeks gestation, and over 100,000 fetuses are exposed to ANCS in the United States
each year. ANCS significantly decreases neonatal mortality and morbidity, but has been associated with
elevated blood pressure, insulin resistance, and reduced renal funcfion in adolescents and young adults.
Our data indicate that 14 year olds who were born with very low birth weight (<1500g) and were exposed
to ANCS show physiological differences that might predispose them to elevated blood pressure later in life.
Specifically, the ANCS-exposed adolescents had lower levels of urinary Angiotensin Converting Enzyme 2,
higher rafios of urinary Angiotensin II (Ang 11) to Angiotensin (1-7), lower urinary sodium levels, and higher
urinary albumin levels. Thesefindingsin humans correspond to our colleagues'findingsthat ANCS-exposed
sheep have reduced nephron number and sodium excretion, alterations in the renin-angiotensin system
(RAS) favoring increased Ang 11 tone, increased blood pressure, insulin resistance, and increased leptin.
ANCS-exposed sheep also have alterations in the central RAS that were associated with decreased heart
rate variability and baroreflex sensitivity, and these alterations preceded the blood pressure elevation. In
addifion, the effects of ANCS in sheep are exacerbated by obesity, which has important implications for our
cohort in which > 34% are ovenweight.
In the current application, we propose to study our human cohort at age 19 years, to assess the
relationship of ANCS exposure to the following: 1) autonomic balance as reflected in heart rate variability
and baroreflex sensitivity, 2) renal sodium handling, as indicated by stress-induced pressure natriuresis, 3)
insulin sensitivity as assessed by oral glucose tolerance testing, 4) levels of circulating adipokines (leptin,
adiponecfin, and resistin), and 5) blood pressure.
We hypothesize that young adults who had very low birth weight and were exposed to ANCS will have
decreased baroreflex sensitivity, decreased ability to excrete sodium, decreased insulin sensitivity,
increased leptin levels, and increased blood pressure, and that these findings will be associated with
alterations in the RAS that promote increased Ang II tone. We will collect data on known modifiable
correlates, such as physical activity, adiposity, and diet. Our studies may identify a population at increased
risk for cardiometabolic disease and inform approaches for monitoring and eariy intervention that will
improve health outcomes of ANCS-exposed individuals as they mature.
RELEVANCE (See instructions):
Corticosteroids are commonly given to pregnant women with threatened preterm delivery to improve the
survival of the infant. Exposure to antenatal steroids may have adverse long-term consequences. These
studies will investigate the long-term effects of antenatal steroid exposure on cardiovascular and metabolic
risk factors with a goal of prevenfing and treafing hypertension and metabolic disease in individuals born
with very low birth weight and exposed prenatally to steroids.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:7005940
-
项目类别:
-
资助金额:$5.92万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Antenatal Steroids Exposure and Adipose Tissue Renin-Angiotensin-System Function
-
批准号:8381682
-
项目类别:
-
资助金额:$19.52万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Antenatal Steroid Exposure and Neural Control of Blood Pressure
-
批准号:8381684
-
项目类别:
-
资助金额:$15.62万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Antenatal Steroids and Cardiometabolic Risk
-
批准号:8712519
-
项目类别:
-
资助金额:$51.19万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
The Impact of Antenatal Steroid Exposure on the Intrarenal Renin-Angiotensin
-
批准号:9264075
-
项目类别:
-
资助金额:$46.76万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
The Impact of Antenatal Steroid Exposure on the Intrarenal Renin-Angiotensin
-
批准号:8918005
-
项目类别:
-
资助金额:$17.27万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Critique of the Overall Program Project Application
-
批准号:7012101
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
ANIMAL CORE
-
批准号:8381688
-
项目类别:
-
资助金额:$34.84万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Prenatal Events-Postnatal Consequences
-
批准号:8712515
-
项目类别:
-
资助金额:$143.36万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Antenatal Steroid Exposure and Neural Control of Blood Pressure
-
批准号:8712518
-
项目类别:
-
资助金额:$14.92万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Prenatal Events-Postnatal Consequences
-
批准号:7280921
-
项目类别:
-
资助金额:$103.81万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Prenatal Events-Postnatal Consequences
-
批准号:7683209
-
项目类别:
-
资助金额:$126.85万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
The Impact of Antenatal Steroid Exposure on the Intrarenal Renin-Angiotensin Syst
-
批准号:7005935
-
项目类别:
-
资助金额:$12.8万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Antenatal Steroid Exposure and Neural Control of Blood Pressure
-
批准号:8212815
-
项目类别:
-
资助金额:$15.98万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Prenatal Events-Postnatal Consequences
-
批准号:7273360
-
项目类别:
-
资助金额:$6.08万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Prenatal Events-Postnatal Consequences
-
批准号:7112462
-
项目类别:
-
资助金额:$97.11万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Prenatal Events-Postnatal Consequences
-
批准号:8531999
-
项目类别:
-
资助金额:$136.85万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Antenatal Steroids Exposure and Adipose Tissue Renin-Angiotensin-System Function
-
批准号:8918006
-
项目类别:
-
资助金额:$19.28万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
The Impact of Antenatal Steroid Exposure on the Intrarenal Renin-Angiotensin
-
批准号:8712516
-
项目类别:
-
资助金额:$16.82万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
ANIMAL CORE
-
批准号:8918010
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
海外基金